Alnylam Pharmaceuticals, Inc. (ALNY)
368.14
+2.68
(+0.73%)
USD |
NASDAQ |
Jan 22, 12:50
Alnylam Pharmaceuticals Research and Development Expense (TTM): 1.248B for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Insmed, Inc. | 695.91M |
| Pfizer Inc. | 10.13B |
| Biogen, Inc. | 1.524B |
| Bristol Myers Squibb Co. | 9.719B |
| Vertex Pharmaceuticals, Inc. | 3.954B |